| Original language | English (US) |
|---|---|
| Pages (from-to) | 33-35 |
| Number of pages | 3 |
| Journal | International Journal of Radiation Oncology Biology Physics |
| Volume | 104 |
| Issue number | 1 |
| DOIs | |
| State | Published - May 1 2019 |
ASJC Scopus subject areas
- Radiation
- Oncology
- Radiology Nuclear Medicine and imaging
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
STAMPEDE : Is Radiation Therapy to the Primary a New Standard of Care in Men with Metastatic Prostate Cancer? / Choudhury, Ananya; Chen, Ronald C.; Henry, Ann et al.
In: International Journal of Radiation Oncology Biology Physics, Vol. 104, No. 1, 01.05.2019, p. 33-35.Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - STAMPEDE
T2 - Is Radiation Therapy to the Primary a New Standard of Care in Men with Metastatic Prostate Cancer?
AU - Choudhury, Ananya
AU - Chen, Ronald C.
AU - Henry, Ann
AU - Mistry, Hitesh
AU - Mitin, Timur
AU - Pinkawa, Michael
AU - Spratt, Daniel E.
N1 - Funding Information: Professor Ananya Choudhury was supported by NIHR Manchester Biomedical Research Centre. Funding Information: Conflict of interest: A.C. reports grants from National Institute of Health Research Manchester Biomedical Research Centre, Cancer Research UK, Medical Research Council UK, Prostate Cancer UK, and Bayer UK and grants and nonfinancial support from Elekta AB, outside the submitted work; R.C. reports grants and personal fees from Accuray, and personal fees from Astellas/Medivation, Bayer, and Blue Earth, outside the submitted work; A.H. reports grants from National Institute for Health Research, Cancer Research UK, and Medical Research Council UK, outside the submitted work; D.E.S. served on a one-time advisory board for Janssen and Blue Earth. Conflict of interest: A.C. reports grants from National Institute of Health Research Manchester Biomedical Research Centre, Cancer Research UK, Medical Research Council UK, Prostate Cancer UK, and Bayer UK and grants and nonfinancial support from Elekta AB, outside the submitted work; R.C. reports grants and personal fees from Accuray, and personal fees from Astellas/Medivation, Bayer, and Blue Earth, outside the submitted work; A.H. reports grants from National Institute for Health Research, Cancer Research UK, and Medical Research Council UK, outside the submitted work; D.E.S. served on a one-time advisory board for Janssen and Blue Earth. Professor Ananya Choudhury was supported by NIHR Manchester Biomedical Research Centre. Conflict of interest: A.C. reports grants from National Institute of Health Research Manchester Biomedical Research Centre, Cancer Research UK, Medical Research Council UK, Prostate Cancer UK, and Bayer UK and grants and nonfinancial support from Elekta AB, outside the submitted work; R.C. reports grants and personal fees from Accuray, and personal fees from Astellas/Medivation, Bayer, and Blue Earth, outside the submitted work; A.H. reports grants from National Institute for Health Research, Cancer Research UK, and Medical Research Council UK, outside the submitted work; D.E.S. served on a one-time advisory board for Janssen and Blue Earth.
PY - 2019/5/1
Y1 - 2019/5/1
UR - http://www.scopus.com/inward/record.url?scp=85063910464&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063910464&partnerID=8YFLogxK
U2 - 10.1016/j.ijrobp.2018.12.040
DO - 10.1016/j.ijrobp.2018.12.040
M3 - Editorial
C2 - 30967237
AN - SCOPUS:85063910464
VL - 104
SP - 33
EP - 35
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
SN - 0360-3016
IS - 1
ER -